U.S. Representative
Jared Moskowitz
DHouseFlorida · District 23
U.S. Representative (D) for Florida, 46 years old.
Tenure
Representative since 2023
Born
Coral Springs, Broward County, Fla., 1980
Prior career
- lawyer
Education
- B.A. George Washington University (2003)
- J.D. Nova Southeastern University (2007)
Full biography
MOSKOWITZ, Jared, a Representative from Florida; born in Coral Springs, Broward County, Fla., December 18, 1980; graduated from Marjory Stoneman Douglas High School, Parkland, Fla., 1999; B.A., George Washington University, Washington, D.C., 2003; J.D., Nova Southeastern University, Davie, Fla., 2007; campaign staff; lawyer, private practice; business executive; Parkland, Fla., city commissioner, 2006-2012; member of the Florida state house of representatives, 2012-2019; director of the Florida department of emergency management, 2019-2021; Broward County, Fla., commissioner, 2022; elected as a Democrat to the One Hundred Eighteenth and to the succeeding Congress (January 3, 2023–present).
Source: U.S. Congress Bioguide / public-record corporate filings.
Year-to-date performance
Return YTD
Up 13.3%
Net Profit YTD
+$28.7K
▼ Trailing S&P 500 by 3.2 pts
52 priced trades counted
Profitable trades
27%
House rank
#29/85
48
Total trades
$504K
Volume YTD
360d
Avg hold
23
Conflicts
Public financial disclosure
Self-reported on House Form A — values are disclosed as ranges, not exact dollars.
Disclosed net worth
⚑ 145 sector overlaps$2.6M – $16.1M
Assets minus liabilities, summed across the 25+ disclosed positions.
- Liabilities
- $1M–$2M
- Form
- Amendment Report 2023
- Filed
- August 2024
Holdings in agency’s regulated sectors
Disclosed positions whose sector overlaps with this agency’s jurisdiction. Structural — not an accusation of wrongdoing. Cabinet officials typically divest these at confirmation.
- AMZNAmazon.com, Inc.$250,001 - $500,000TechnologyRepresentative on 4 committees including Committee on Foreign Affairs holds Technology-sector security; this committee has substantive jurisdiction over this sector.
- Seacoast Bank Gift Trust (DC 1)$100,001 - $250,000Financial ServicesRepresentative on 4 committees including Committee on Foreign Affairs holds Financial Services-sector security; this committee has substantive jurisdiction over this sector.
- ST Bank of India Chicago IL CD$100,001 - $250,000Financial ServicesRepresentative on 4 committees including Committee on Foreign Affairs holds Financial Services-sector security; this committee has substantive jurisdiction over this sector.
- Bank Account (DC 2)$100,001 - $250,000Financial ServicesRepresentative on 4 committees including Committee on Foreign Affairs holds Financial Services-sector security; this committee has substantive jurisdiction over this sector.
- NBT Bank CD Norwich NY CD$100,001 - $250,000Financial ServicesRepresentative on 4 committees including Committee on Foreign Affairs holds Financial Services-sector security; this committee has substantive jurisdiction over this sector.
- Bank Account (DC 1)$100,001 - $250,000Financial ServicesRepresentative on 4 committees including Committee on Foreign Affairs holds Financial Services-sector security; this committee has substantive jurisdiction over this sector.
Largest holdings
- 1.Cash Accounts$1,000,001 - $5,000,000
- 2.MOD LLC$250,001 - $500,000
- 3.Cash Account$250,001 - $500,000
- 4.Marcus Savings Account$250,001 - $500,000
- 5.Marcus CD$250,001 - $500,000
- 6.Goldman Sachs Savings Account$250,001 - $500,000
- 7.AMZNAmazon.com, Inc.⚑Technology$250,001 - $500,000
- 8.Charles Schwab Westlake TX CD$100,001 - $250,000
- 9.Bank Account (DC 2)⚑Financial Services$100,001 - $250,000
- 10.Seacoast Bank Gift Trust (DC 1)⚑Financial Services$100,001 - $250,000
- 11.ST Bank of India Chicago IL CD⚑Financial Services$100,001 - $250,000
- 12.Bank of China New York NY CD⚑Financial Services$100,001 - $250,000
- 13.Industrial & Coml New York NY CD$100,001 - $250,000
- 14.Bank Account (DC 1)⚑Financial Services$100,001 - $250,000
- 15.Seacoast Bank Gift Trust (DC 2)⚑Financial Services$100,001 - $250,000
- 16.NBT Bank CD Norwich NY CD⚑Financial Services$100,001 - $250,000
- 17.MainStay Growth Allocation Class A$50,001 - $100,000
- 18.US Bk Natl Assn Cincinnati OH CD$50,001 - $100,000
- 19.Bank of China New York NY CD⚑Financial Services$50,001 - $100,000
- 20.AAPLApple Inc.⚑Technology$50,001 - $100,000
- 21.Bank of America Accounts⚑Financial Services$50,001 - $100,000
- 22.CD GOLDMAN SACHS BK USA$50,001 - $100,000
- 23.Cash Account$50,001 - $100,000
- 24.GSGoldman Sachs Group, Inc.⚑Banking$15,001 - $50,000
- 25.RGABXAmerican Funds The Growth Fund of America® Class R-2$15,001 - $50,000
Track record by window
Year to date
+$28.7K
+13.3%
Gross flow$504K
Trades52
Bought / Sold27·25
Open book52%
Public-record gap+9.0%
1 year
+$208.8K
+41.2%
Gross flow$972K
Trades86
Bought / Sold48·38
Open book56%
Public-record gap+39.0%
5 years
+$806.5K
+36.0%
Gross flow$4.3M
Trades428
Bought / Sold270·158
Open book63%
Public-record gap+38.8%
Best call · 1Y
↑bought
Dell Technologies (DELL)+$61.5K(+189.3%)
Bought at $150.57 on Oct 10, 2025 · now $435.63
Common Stock (DELL)
Worst call · 1Y
↑bought
Cencora (COR)−$1.4K(-17.1%)
Bought at $320.61 on Mar 23, 2026 · now $265.69
Disclosed trades · 48 of 425
All filings →●Filed Apr 30, 2026·traded Mar 23, 2026
↓sold
Brown & Brown, Inc. Common Stock (BRO)(BRO)$1K-$15K
38 days to discloseDependent
⚑ Financial Services · OversightFlat·+0.0%
+5.2% vs S&P 500●Filed Apr 30, 2026·traded Mar 23, 2026
↓soldBrown & Brown, Inc. Common Stock (BRO)(BRO)$1K-$15K
38 days to discloseDependent
⚑ Financial Services · OversightFlat·+0.0%
+5.2% vs S&P 500●Filed Apr 30, 2026·traded Mar 23, 2026
↑bought
Palo Alto Networks, Inc. (PANW)(PANW)$1K-$15K
38 days to discloseDependent
⚑ Technology · Committee on the JudiciaryGood buy·+$6.3K+79.3%
+43.3% vs S&P 500●Filed Apr 30, 2026·traded Mar 23, 2026
↓sold
The Cigna Group Common Stock (CI)(CI)$1K-$15K
38 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+2.6% vs S&P 500●Filed Apr 30, 2026·traded Mar 23, 2026
↑boughtCencora, Inc. Common Stock (COR)(COR)$1K-$15K
38 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$1.4K-17.1%
−19.7% vs S&P 500●Filed Nov 22, 2025·traded Oct 10, 2025
↓sold
Johnson & Johnson Common Stock (JNJ)(JNJ)$1K-$15K
43 days to discloseDependent
Flat·+0.0%
+4.5% vs S&P 500●Filed Nov 22, 2025·traded Oct 10, 2025
↓sold
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K43 days to discloseDependent
Flat·+0.0%
+18.4% vs S&P 500●Filed Nov 22, 2025·traded Oct 10, 2025
↓sold
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K43 days to discloseDependent
Flat·+0.0%
+18.4% vs S&P 500●Filed Nov 22, 2025·traded Oct 10, 2025
↓soldJohnson & Johnson Common Stock (JNJ)(JNJ)$1K-$15K
43 days to discloseDependent
Flat·+0.0%
+4.5% vs S&P 500●Filed Jun 27, 2025·traded May 15, 2025
↑boughtThe Cigna Group Common Stock (CI)(CI)$1K-$15K
43 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$912-11.4%
−25.2% vs S&P 500●Filed May 9, 2025·traded Apr 16, 2025
↑bought
Amgen Inc. - Common Stock (AMGN)(AMGN)$1K-$15K
23 days to discloseDependent
Good buy·+$1.3K+16.4%
+7.4% vs S&P 500●Filed Apr 8, 2025·traded Mar 10, 2025
↓sold
Elevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
29 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+0.6% vs S&P 500●Filed Apr 8, 2025·traded Mar 10, 2025
↓soldElevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
29 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+0.6% vs S&P 500●Filed Feb 10, 2025·traded Jan 15, 2025
↓sold
Abbott Laboratories Common Stock (ABT)(ABT)$1K-$15K
26 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+5.6% vs S&P 500●Filed Feb 10, 2025·traded Jan 15, 2025
↑bought
Stryker Corporation Common Stock (SYK)(SYK)$1K-$15K
26 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$1.6K-20.4%
−26.0% vs S&P 500●Filed Feb 10, 2025·traded Jan 15, 2025
↓soldAbbott Laboratories Common Stock (ABT)(ABT)$1K-$15K
26 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+5.6% vs S&P 500●Filed Feb 10, 2025·traded Jan 15, 2025
↑bought
AbbVie Inc. Common Stock (ABBV)(ABBV)$1K-$15K
26 days to discloseDependent
Good buy·+$1.9K+24.2%
+18.5% vs S&P 500●Filed Feb 10, 2025·traded Jan 15, 2025
↑boughtStryker Corporation Common Stock (SYK)(SYK)$1K-$15K
26 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$1.6K-20.4%
−26.0% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑bought
Cummins Inc. Common Stock (CMI)(CMI)$1K-$15K
31 days to discloseDependent
Good buy·+$7K+87.7%
+65.1% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑boughtElevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
31 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$479-6.0%
−4.9% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑boughtJohnson & Johnson Common Stock (JNJ)(JNJ)$1K-$15K
31 days to discloseDependent
Good buy·+$3.9K+48.8%
+49.9% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑bought
L
Linde plc - Ordinary Shares (LIN)(LIN)$1K-$15K31 days to discloseDependent
Good buy·+$738+9.2%
+0.4% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑bought
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K31 days to discloseDependent
Bad buy·−$1.9K-24.0%
−32.8% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑bought
L
Linde plc - Ordinary Shares (LIN)(LIN)$1K-$15K31 days to discloseDependent
Good buy·+$738+9.2%
+0.4% vs S&P 500●Filed Dec 9, 2024·traded Nov 8, 2024
↑boughtCummins Inc. Common Stock (CMI)(CMI)$1K-$15K
31 days to discloseDependent
Good buy·+$7K+87.7%
+65.1% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↑bought
L
Linde plc - Ordinary Shares (LIN)(LIN)$1K-$15K32 days to discloseDependent
Good buy·+$1.2K+15.2%
−1.8% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↑boughtElevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
32 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$2K-25.1%
−27.9% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↓sold
Z
Zoetis Inc. Class A Common Stock (ZTS)(ZTS)$1K-$15K32 days to discloseDependent
Flat·+0.0%
+2.8% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↑bought
L
Linde plc - Ordinary Shares (LIN)(LIN)$1K-$15K32 days to discloseDependent
Good buy·+$1.2K+15.2%
−1.8% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↓sold
Z
Zoetis Inc. Class A Common Stock (ZTS)(ZTS)$1K-$15K32 days to discloseDependent
Flat·+0.0%
+2.8% vs S&P 500●Filed Aug 6, 2024·traded Jul 5, 2024
↑bought
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K32 days to discloseDependent
Bad buy·−$54-0.7%
−17.6% vs S&P 500●Filed Aug 6, 2024·traded Jul 1, 2024
↓sold
B
Best Buy Co., Inc. Common Stock (BBY)(BBY)$1K-$15K36 days to discloseDependent
Flat·+0.0%
+30.5% vs S&P 500●Filed Aug 6, 2024·traded Jul 1, 2024
↑boughtElevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
36 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$2K-25.1%
−27.6% vs S&P 500●Filed Aug 6, 2024·traded Jul 1, 2024
↑bought
N
NextEra Energy, Inc. Common Stock (NEE)(NEE)$1K-$15K36 days to discloseDependent
Good buy·+$2.9K+36.5%
+3.1% vs S&P 500●Filed Aug 6, 2024·traded Jul 1, 2024
↑boughtJohnson & Johnson Common Stock (JNJ)(JNJ)$1K-$15K
36 days to discloseDependent
Good buy·+$4.6K+58.0%
+55.5% vs S&P 500●Filed Aug 6, 2024·traded Feb 1, 2024
↑boughtElevance Health, Inc. Common Stock (ELV)(ELV)$1K-$15K
187 days to disclose · 142 past 45-day windowDependent
⚑ Healthcare · OversightBad buy·−$1.6K-19.8%
−24.2% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
J
Jack Henry & Associates, Inc. (JKHY)(JKHY)$1K-$15K25 days to discloseDependent
⚑ Technology · Committee on the JudiciaryFlat·+0.0%
+91.8% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↑bought
W
West Pharmaceutical Services, Inc. (WST)(WST)$1K-$15K25 days to discloseDependent
⚑ Healthcare · OversightBad buy·−$955-11.9%
−20.9% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
J
Jack Henry & Associates, Inc. (JKHY)(JKHY)$1K-$15K25 days to discloseDependent
⚑ Technology · Committee on the JudiciaryFlat·+0.0%
+91.8% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
H
Hormel Foods Corporation (HRL)(HRL)$1K-$15K25 days to discloseDependent
Flat·+0.0%
+16.3% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K25 days to discloseDependent
Flat·+0.0%
+19.7% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↑bought
Meta Platforms, Inc. - Class A (META)(META)$1K-$15K
25 days to discloseDependent
⚑ Technology · Committee on the JudiciaryGood buy·+$5.3K+66.8%
−25.0% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
H
Hormel Foods Corporation (HRL)(HRL)$1K-$15K25 days to discloseDependent
Flat·+0.0%
+16.3% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
S
Sherwin-Williams Company (SHW)(SHW)$1K-$15K25 days to discloseDependent
Flat·+0.0%
+19.7% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓sold
Medtronic plc. Ordinary Shares (MDT)(MDT)$1K-$15K
25 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+9.0% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↓soldMedtronic plc. Ordinary Shares (MDT)(MDT)$1K-$15K
25 days to discloseDependent
⚑ Healthcare · OversightFlat·+0.0%
+9.0% vs S&P 500●Filed Jan 22, 2024·traded Dec 28, 2023
↑boughtMeta Platforms, Inc. - Class A (META)(META)$1K-$15K
25 days to discloseDependent
⚑ Technology · Committee on the JudiciaryGood buy·+$5.3K+66.8%
−25.0% vs S&P 500●Filed Mar 10, 2023·traded Feb 21, 2023
↑bought
H
Hormel Foods Corporation (HRL)(HRL)$1K-$15K17 days to discloseDependent
Bad buy·−$4.4K-54.5%
−68.4% vs S&P 500| Filed | Trade date | Type | Stock | Smart move? | Size |
|---|---|---|---|---|---|
| Apr 30, 2026 | Mar 23, 2026 38 days to disclose | ↓sold | Brown & Brown, Inc. Common Stock (BRO) Morgan Stanley Active Assets (5) ⚑ Financial Services · Oversight | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 30, 2026 | Mar 23, 2026 38 days to disclose | ↓sold | Brown & Brown, Inc. Common Stock (BRO) ⚑ Financial Services · Oversight | Flat·+0.0% +5.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 30, 2026 | Mar 23, 2026 38 days to disclose | ↑bought | Palo Alto Networks, Inc. (PANW) ⚑ Technology · Committee on the Judiciary | Good buy·+$6.3K+79.3% +43.3% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 30, 2026 | Mar 23, 2026 38 days to disclose | ↓sold | The Cigna Group Common Stock (CI) ⚑ Healthcare · Oversight | Flat·+0.0% +2.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 30, 2026 | Mar 23, 2026 38 days to disclose | ↑bought | Cencora, Inc. Common Stock (COR) ⚑ Healthcare · Oversight | Bad buy·−$1.4K-17.1% −19.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Nov 22, 2025 | Oct 10, 2025 43 days to disclose | ↓sold | Johnson & Johnson Common Stock (JNJ) Morgan Stanley Active Assets (6) | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Nov 22, 2025 | Oct 10, 2025 43 days to disclose | ↓sold | S SHWDependentSherwin-Williams Company (SHW) | Flat·+0.0% +18.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Nov 22, 2025 | Oct 10, 2025 43 days to disclose | ↓sold | S SHWDependentSherwin-Williams Company (SHW) Morgan Stanley Active Assets (6) | Flat·+0.0% +18.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Nov 22, 2025 | Oct 10, 2025 43 days to disclose | ↓sold | Johnson & Johnson Common Stock (JNJ) Morgan Stanley Active Assets (5) | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jun 27, 2025 | May 15, 2025 43 days to disclose | ↑bought | The Cigna Group Common Stock (CI) ⚑ Healthcare · Oversight | Bad buy·−$912-11.4% −25.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| May 9, 2025 | Apr 16, 2025 23 days to disclose | ↑bought | Amgen Inc. - Common Stock (AMGN) | Good buy·+$1.3K+16.4% +7.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 8, 2025 | Mar 10, 2025 29 days to disclose | ↓sold | Elevance Health, Inc. Common Stock (ELV) ⚑ Healthcare · Oversight | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Apr 8, 2025 | Mar 10, 2025 29 days to disclose | ↓sold | Elevance Health, Inc. Common Stock (ELV) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Flat·+0.0% +0.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Feb 10, 2025 | Jan 15, 2025 26 days to disclose | ↓sold | Abbott Laboratories Common Stock (ABT) Morgan Stanley Active Assets (6) ⚑ Healthcare · Oversight | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Feb 10, 2025 | Jan 15, 2025 26 days to disclose | ↑bought | Stryker Corporation Common Stock (SYK) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Bad buy·−$1.6K-20.4% −26.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Feb 10, 2025 | Jan 15, 2025 26 days to disclose | ↓sold | Abbott Laboratories Common Stock (ABT) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Flat·+0.0% +5.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Feb 10, 2025 | Jan 15, 2025 26 days to disclose | ↑bought | AbbVie Inc. Common Stock (ABBV) | Good buy·+$1.9K+24.2% +18.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Feb 10, 2025 | Jan 15, 2025 26 days to disclose | ↑bought | Stryker Corporation Common Stock (SYK) Morgan Stanley Active Assets (6) ⚑ Healthcare · Oversight | Bad buy·−$1.6K-20.4% −26.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | Cummins Inc. Common Stock (CMI) Morgan Stanley Active Assets (5) | Good buy·+$7K+87.7% +65.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | Elevance Health, Inc. Common Stock (ELV) ⚑ Healthcare · Oversight | Bad buy·−$479-6.0% −4.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | Johnson & Johnson Common Stock (JNJ) Morgan Stanley Active Assets (5) | Good buy·+$3.9K+48.8% +49.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | L LINDependentLinde plc - Ordinary Shares (LIN) Morgan Stanley Active Assets (5) | Good buy·+$738+9.2% +0.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | S SHWDependentSherwin-Williams Company (SHW) | Bad buy·−$1.9K-24.0% −32.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | L LINDependentLinde plc - Ordinary Shares (LIN) Morgan Stanley Active Assets (6) | Good buy·+$738+9.2% +0.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Dec 9, 2024 | Nov 8, 2024 31 days to disclose | ↑bought | Cummins Inc. Common Stock (CMI) Morgan Stanley Active Assets (6) | Good buy·+$7K+87.7% +65.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↑bought | L LINDependentLinde plc - Ordinary Shares (LIN) Morgan Stanley Active Assets (5) | Good buy·+$1.2K+15.2% −1.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↑bought | Elevance Health, Inc. Common Stock (ELV) Morgan Stanley Active Assets (6) ⚑ Healthcare · Oversight | Bad buy·−$2K-25.1% −27.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↓sold | Z ZTSDependentZoetis Inc. Class A Common Stock (ZTS) Morgan Stanley Active Assets (5) | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↑bought | L LINDependentLinde plc - Ordinary Shares (LIN) Morgan Stanley Active Assets (6) | Good buy·+$1.2K+15.2% −1.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↓sold | Z ZTSDependentZoetis Inc. Class A Common Stock (ZTS) Morgan Stanley Active Assets (6) | Flat·+0.0% +2.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 5, 2024 32 days to disclose | ↑bought | S SHWDependentSherwin-Williams Company (SHW) Morgan Stanley Active Assets (5) | Bad buy·−$54-0.7% −17.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 1, 2024 36 days to disclose | ↓sold | B BBYDependentBest Buy Co., Inc. Common Stock (BBY) Morgan Stanley Active Assets (5) | Flat·+0.0% +30.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 1, 2024 36 days to disclose | ↑bought | Elevance Health, Inc. Common Stock (ELV) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Bad buy·−$2K-25.1% −27.6% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 1, 2024 36 days to disclose | ↑bought | N NEEDependentNextEra Energy, Inc. Common Stock (NEE) Morgan Stanley Active Assets (5) | Good buy·+$2.9K+36.5% +3.1% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Jul 1, 2024 36 days to disclose | ↑bought | Johnson & Johnson Common Stock (JNJ) | Good buy·+$4.6K+58.0% +55.5% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Aug 6, 2024 | Feb 1, 2024 187 days to disclose · 142 past 45-day window | ↑bought | Elevance Health, Inc. Common Stock (ELV) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Bad buy·−$1.6K-19.8% −24.2% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | J JKHYDependentJack Henry & Associates, Inc. (JKHY) Morgan Stanley Active Assets (5) ⚑ Technology · Committee on the Judiciary | Flat·+0.0% +91.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↑bought | W WSTDependentWest Pharmaceutical Services, Inc. (WST) Morgan Stanley Active Assets (6) ⚑ Healthcare · Oversight | Bad buy·−$955-11.9% −20.9% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | J JKHYDependentJack Henry & Associates, Inc. (JKHY) Morgan Stanley Active Assets (6) ⚑ Technology · Committee on the Judiciary | Flat·+0.0% +91.8% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | H HRLDependentHormel Foods Corporation (HRL) Morgan Stanley Active Assets (5) | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | S SHWDependentSherwin-Williams Company (SHW) Morgan Stanley Active Assets (5) | Flat·+0.0% +19.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↑bought | Meta Platforms, Inc. - Class A (META) Morgan Stanley Active Assets (5) ⚑ Technology · Committee on the Judiciary | Good buy·+$5.3K+66.8% −25.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | H HRLDependentHormel Foods Corporation (HRL) Morgan Stanley Active Assets (6) | Flat·+0.0% +16.3% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | S SHWDependentSherwin-Williams Company (SHW) | Flat·+0.0% +19.7% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | Medtronic plc. Ordinary Shares (MDT) Morgan Stanley Active Assets (6) ⚑ Healthcare · Oversight | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↓sold | Medtronic plc. Ordinary Shares (MDT) Morgan Stanley Active Assets (5) ⚑ Healthcare · Oversight | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Jan 22, 2024 | Dec 28, 2023 25 days to disclose | ↑bought | Meta Platforms, Inc. - Class A (META) Morgan Stanley Active Assets (6) ⚑ Technology · Committee on the Judiciary | Good buy·+$5.3K+66.8% −25.0% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
| Mar 10, 2023 | Feb 21, 2023 17 days to disclose | ↑bought | H HRLDependentHormel Foods Corporation (HRL) Morgan Stanley Active Assets (5) | Bad buy·−$4.4K-54.5% −68.4% vs S&P 500 | $1K-$15K $1,001 - $15,000 2.1% of book |
Their record vs the S&P 500
48 priced trades compared to a same-direction S&P 500 benchmark.
Politician portfolio+$30.8K
S&P 500 benchmark+$5.6K
Alpha+$25.2K
Gold line = cumulative dollar P&L · Dashed = S&P 500 over same window · Bars = monthly trade volume
Oversight committees · 7
Click any committee to see what it actually does, which sectors it regulates, and why each sector tag was attached. Sources cited.
Recent legislative activity · 40 bills
20 sponsored, 20 cosponsored in the 119th Congress. Color-coded by sector — yellow chips mark bills that overlap a sector this politician has actually traded in.
- Banning SPR Oil Exports to Foreign Adversaries ActReferred to the House Committee on Energy and Commerce.
- Expanding Access to Mental Health Services in Schools Act of 2025Referred to the House Committee on Education and Workforce.
- 988 LGBTQ+ Youth Access Act of 2025Referred to the House Committee on Energy and Commerce.
- John Lewis Every Child Deserves a Family ActReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Secret Service Transfer Act of 2026Referred to the Committee on the Judiciary, and in addition to the Committee on Homeland Security, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Transportation Security Administration Transfer Act of 2026Referred to the House Committee on Homeland Security.
- Resolution memorializing law enforcement officers killed in the line of duty.Motion to reconsider laid on the table Agreed to without objection.
- Calling on elected officials and civil society leaders to counter antisemitism and educate the public on the contributions of the Jewish-American community.Motion to reconsider laid on the table Agreed to without objection.
- Condemning antisemitic hate-filled rhetoric and content disseminated by prominent online personalities, and urging social media platforms and public leaders to denounce and address such conduct.Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- To require the Secretary of State to annually issue a list of of People's Republic of China-origin entities carrying out mining involving forced labor or causing environmental harm in certain African countries, and for other purposes.Referred to the House Committee on Foreign Affairs.
- SCREENS for Cancer Act of 2025Referred to the House Committee on Energy and Commerce.
- Metastatic Breast Cancer Access to Care ActReferred to the House Committee on Ways and Means.
- To designate the facility of the United States Postal Service located at 3255 Northwest 94th Avenue in Coral Springs, Florida, as the "Nancy Metayer Post Office Building".Referred to the House Committee on Oversight and Government Reform.
- Post-Disaster Protection ActReferred to the House Committee on Transportation and Infrastructure.
- Artemis Accords Authorization ActReferred to the House Committee on Foreign Affairs.
- PrEP Access and Coverage Act of 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on Oversight and Government Reform, Ways and Means, Veterans' Affairs, Armed Services, Natural Resources, Financial Services, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- To appropriate funds for the Federal Emergency Management Agency's Disaster Relief Fund, and for other purposes.Referred to the Committee on Appropriations, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- To designate the facility of the United States Postal Service located at 3135 1st Avenue North in St. Petersburg, Florida, as the "Poul Hornsleth Post Office".Referred to the House Committee on Oversight and Government Reform.
- Protecting Patient Access to Cancer and Complex Therapies ActReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- GRACIE Act of 2026Referred to the House Committee on Ways and Means.